Oncology & Cancer

Researchers ID drug that blocks some blood cancers

A compound identified by Weill Cornell Medicine scientists inhibits the growth of a rare blood cancer found in people with HIV-AIDS. Their research, published May 15 in the Journal of Clinical Investigation, also demonstrates ...

Immunology

Rescue protein gives doomed cells a stay of 'execution'

A research team led by St. Jude Children's Research Hospital immunologists has discovered how a set of proteins delays the "executioner" machinery that kills damaged or infected cells in a process called necroptosis. The ...

Oncology & Cancer

Researchers discover underlying cause of myeloma

Yale Cancer Center researchers have identified what causes a third of all myelomas, a type of cancer affecting plasma cells. The findings, published Feb. 10 in the New England Journal of Medicine, could fundamentally change ...

Immunology

Important regulator of immune system decoded

Our environment teems with microorganisms and viruses that are potentially harmful. The reason why we survive their daily attacks is the ability of the immune system to neutralize these invaders in numerous ways. Plasma cells ...

Diabetes

How leptin, the 'satiety hormone,' reverses diabetes

(Medical Xpress)—Treatment with leptin, the hormone associated with fullness or satiety, reverses hyperglycemia in animals models of poorly controlled type 1 (T1D) and type 2 (T2D) diabetes by suppressing the neuroendocrine ...

page 6 from 31